Eikenes, G.; Liszkay, G.; Balatoni, T.; Czirbesz, K.; Hunyadi, K.; Kozéki, Z.; Kispál, M.T.; Baranyai, F.; Danyi, T.; Bőcs, K.;
et al. Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients. Cancers 2023, 15, 3966.
https://doi.org/10.3390/cancers15153966
AMA Style
Eikenes G, Liszkay G, Balatoni T, Czirbesz K, Hunyadi K, Kozéki Z, Kispál MT, Baranyai F, Danyi T, Bőcs K,
et al. Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients. Cancers. 2023; 15(15):3966.
https://doi.org/10.3390/cancers15153966
Chicago/Turabian Style
Eikenes, Grethe, Gabriella Liszkay, Tímea Balatoni, Kata Czirbesz, Karen Hunyadi, Zsófia Kozéki, Mihály Tamás Kispál, Fanni Baranyai, Tímea Danyi, Katalin Bőcs,
and et al. 2023. "Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients" Cancers 15, no. 15: 3966.
https://doi.org/10.3390/cancers15153966
APA Style
Eikenes, G., Liszkay, G., Balatoni, T., Czirbesz, K., Hunyadi, K., Kozéki, Z., Kispál, M. T., Baranyai, F., Danyi, T., Bőcs, K., & Kenessey, I.
(2023). Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients. Cancers, 15(15), 3966.
https://doi.org/10.3390/cancers15153966
